Coronavirus Update: Hudson’s Remarks On US ‘First Rights’ Stirs Vaccine Row
Draws Criticism From French Government
Company clarifies by saying it has production capacity in Europe as well as US and other regions - but follows Hudson's calls for Europe to develop its own BARDA-like agency.
You may also be interested in...
Paul Hudson has been at the helm of Sanofi for just nine months, but for the last few days his comments about which country will be first in line for the firm's coronavirus vaccines will have reminded him that the Gallic culture runs deep.
Plus: Eli Lilly extends its presence in COVID-19 research with an alliance with China's Junshi Biosciences.
Promising Early Results For AZ And Daiichi’s Dato-DXd In Breast Cancer – But How Soon Can They File?
Once again choosing their words carefully, the partners talk only of ‘plans’ to file as regulators will first have to clarify when overall survival data will be required for the new antibody-drug conjugate in breast cancer.